• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enGene Holdings Inc. - Common Stock (NQ:ENGN)

7.330 +0.090 (+1.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 357,799
Open 7.190
Bid (Size) 7.330 (100)
Ask (Size) 7.750 (200)
Prev. Close 7.240
Today's Range 7.080 - 7.699
52wk Range 2.650 - 12.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
enGene Announces Name Change to enGene Therapeutics Inc.
April 07, 2026
From enGene Therapeutics Inc.
Via Business Wire
News headline image
This Biotech Was Quietly Bought Before a $58 Per Share Takeout ↗
March 21, 2026
This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials. 
Via The Motley Fool

Performance

YTD
-17.2%
-17.2%
1 Month
+4.0%
+4.0%
3 Month
-11.3%
-11.3%
6 Month
+4.6%
+4.6%
1 Year
+56.6%
+56.6%

More News

Read More
News headline image
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
March 09, 2026
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Participate in Upcoming Investor Conferences
February 20, 2026
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 20, 2026
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Reports Full Year 2025 Financial Results and Provides Business Update
December 22, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 02, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 18, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 13, 2025
Via Benzinga
News headline image
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Announces Proposed Public Offering of Common Shares
November 12, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
November 11, 2025
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
November 11, 2025
Via Chartmill
News headline image
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗
November 11, 2025
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
November 11, 2025
Via Benzinga
News headline image
EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial ↗
November 11, 2025
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
November 11, 2025
Via Chartmill
News headline image
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗
November 11, 2025
Via Benzinga
News headline image
ENGN Stock Soars On Hopeful Data From Bladder Cancer Study ↗
November 11, 2025
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
November 11, 2025
Via Chartmill
News headline image
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
November 11, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
November 10, 2025
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Participate in Upcoming Investor Conferences
November 06, 2025
From enGene Holdings Inc.
Via Business Wire

Frequently Asked Questions

Is enGene Holdings Inc. - Common Stock publicly traded?
Yes, enGene Holdings Inc. - Common Stock is publicly traded.
What exchange does enGene Holdings Inc. - Common Stock trade on?
enGene Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Holdings Inc. - Common Stock?
The ticker symbol for enGene Holdings Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Holdings Inc. - Common Stock?
The current price of enGene Holdings Inc. - Common Stock is 7.330
When was enGene Holdings Inc. - Common Stock last traded?
The last trade of enGene Holdings Inc. - Common Stock was at 04/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap